GT200800115A - Metodos para tratar infecciones del tracto gastrointestinal con tigeciclina - Google Patents
Metodos para tratar infecciones del tracto gastrointestinal con tigeciclinaInfo
- Publication number
- GT200800115A GT200800115A GT200800115A GT200800115A GT200800115A GT 200800115 A GT200800115 A GT 200800115A GT 200800115 A GT200800115 A GT 200800115A GT 200800115 A GT200800115 A GT 200800115A GT 200800115 A GT200800115 A GT 200800115A
- Authority
- GT
- Guatemala
- Prior art keywords
- tigecicline
- methods
- gastrointestinal tract
- tract infections
- treat gastrointestinal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
EN LA PRESENTE SOLICITUD SE DESCRIBEN MÉTODOS PARA TRATAR AL MENOS UNA INFECCIÓN BACTERIANA, TAL COMO INFECCIONES GASTROINTESTINALES INFERIORES, QUE COMPRENDEN ADMINISTRAR ORALMENTE UNA COMPOSICIÓN FARMACÉUTICA QUE COMPRENDE TIGECICLINA. LA COMPOSICIÓN PUEDE TOMAR FORMAS SÓLIDAS O LÍQUIDAS, TAL COMO SOLUCIONES, DISPERSIONES O FORMAS SÓLIDAS QUE COMPRENDEN TIGECICLINA QUE TIENE AL MENOS UN REVESTIMIENTO ENTÉRICO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75316105P | 2005-12-22 | 2005-12-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200800115A true GT200800115A (es) | 2009-01-16 |
Family
ID=37963595
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200800115A GT200800115A (es) | 2005-12-22 | 2008-06-19 | Metodos para tratar infecciones del tracto gastrointestinal con tigeciclina |
Country Status (15)
Country | Link |
---|---|
US (1) | US20070243244A1 (es) |
EP (1) | EP1962860A1 (es) |
JP (1) | JP2009521456A (es) |
KR (1) | KR20080085184A (es) |
CN (1) | CN101340917A (es) |
AU (1) | AU2006331685A1 (es) |
BR (1) | BRPI0620430A2 (es) |
CA (1) | CA2631632A1 (es) |
CR (1) | CR10023A (es) |
EC (1) | ECSP088634A (es) |
GT (1) | GT200800115A (es) |
IL (1) | IL191598A0 (es) |
NO (1) | NO20082396L (es) |
RU (1) | RU2008121238A (es) |
WO (1) | WO2007075792A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20080005599A (ko) * | 2005-05-06 | 2008-01-14 | 와이어쓰 | 헤파린 존재하에 티게사이클린의 전달 |
CA2723424A1 (en) * | 2008-05-19 | 2009-11-26 | Burnham Institute For Medical Research | Intestinal alkaline phosphatase modulators and uses thereof |
AU2011252919B2 (en) * | 2010-05-12 | 2017-01-19 | Melinta Therapeutics, Inc. | Tetracycline compositions |
CN103356662B (zh) * | 2012-03-27 | 2015-11-25 | 浙江医药股份有限公司新昌制药厂 | 注射用替加环素组合物及其制备方法 |
CN103263400B (zh) * | 2013-01-16 | 2014-12-17 | 内蒙古金河动物药业有限公司 | 一种金霉素微囊制剂及其制备方法 |
ES2774962T3 (es) * | 2013-03-05 | 2020-07-23 | Enteris Biopharma Inc | Productos farmacéuticos de administración oral |
CA2973099C (en) | 2015-01-12 | 2021-09-14 | Enteris Biopharma, Inc. | Solid oral dosage forms |
BR122024000249A2 (pt) * | 2016-03-24 | 2024-02-27 | Paratek Pharmaceuticals, Inc. | Uso de um composto ou um sal do mesmo |
CN111166729A (zh) * | 2020-03-19 | 2020-05-19 | 珠海赛隆药业股份有限公司 | 一种口服的替加环素肠溶微球及其制备方法 |
CN112843071A (zh) * | 2020-09-08 | 2021-05-28 | 天津国际生物医药联合研究院 | 土霉素或者替加环素在抗分枝杆菌感染中的潜在应用 |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3026248A (en) * | 1959-09-11 | 1962-03-20 | Pfizer & Co C | Thioglycerol and formaldehyde sulfoxylate stabilized tetracycline antibiotics in polyhydric alcohol solvents |
US3219529A (en) * | 1962-10-04 | 1965-11-23 | American Cyanamid Co | Stable tetracycline solutions |
US5281628A (en) * | 1991-10-04 | 1994-01-25 | American Cyanamid Company | 9-amino-7-(substituted)-6-demethyl-6-deoxytetracyclines |
US5494903A (en) * | 1991-10-04 | 1996-02-27 | American Cyanamid Company | 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines |
US5167964A (en) * | 1992-02-14 | 1992-12-01 | Warner-Lambert Company | Semi-enteric drug delivery systems and methods for preparing same |
SG47520A1 (en) * | 1992-08-13 | 1998-04-17 | American Cyanamid Co | New method for the production of 9-amino-6-demethyl-6-deoxytetracycline |
US5420272A (en) * | 1992-08-13 | 1995-05-30 | American Cyanamid Company | 7-(substituted)-8-(substituted)-9-](substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines |
US5284963A (en) * | 1992-08-13 | 1994-02-08 | American Cyanamid Company | Method of producing 7-(substituted)-9-[(substituted glycyl)-amidol]-6-demethyl-6-deoxytetra-cyclines |
US5328902A (en) * | 1992-08-13 | 1994-07-12 | American Cyanamid Co. | 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines |
CA2183565A1 (en) * | 1994-02-17 | 1995-08-24 | Wei-Guo Su | 9-(substituted amino)-alpha-6-deoxy-5-oxy tetracycline derivatives, their preparation and their use as antibiotics |
US5675030A (en) * | 1994-11-16 | 1997-10-07 | American Cyanamid Company | Method for selective extracting a 7-(hydrogen or substituted amino)-9- (substituted glycyl) amido!-6-demethyl-6-deoxytetracycline compound |
US5567693A (en) * | 1994-12-13 | 1996-10-22 | American Cyanamid Company | Method for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth |
US6063775A (en) * | 1997-04-29 | 2000-05-16 | Berman; Charles L. | Retardation of metalloproteinase incidental to HIV and/or AIDS |
US5908838A (en) * | 1998-02-19 | 1999-06-01 | Medics Pharmaceutical Corporation | Method for the treatment of acne |
US6015803A (en) * | 1998-05-04 | 2000-01-18 | Wirostko; Emil | Antibiotic treatment of age-related macular degeneration |
US6015804A (en) * | 1998-09-11 | 2000-01-18 | The Research Foundation Of State University Of New York | Method of using tetracycline compounds to enhance interleukin-10 production |
US5998390A (en) * | 1998-09-28 | 1999-12-07 | The Research Foundation Of State University Of New York | Combination of bisphosphonate and tetracycline |
US6506740B1 (en) * | 1998-11-18 | 2003-01-14 | Robert A. Ashley | 4-dedimethylaminotetracycline derivatives |
US20040131628A1 (en) * | 2000-03-08 | 2004-07-08 | Bratzler Robert L. | Nucleic acids for the treatment of disorders associated with microorganisms |
IL151971A0 (en) * | 2000-03-31 | 2003-04-10 | Tufts College | 7-and 9-carbamate, urea, thiourea, thiocarbabamate, and heteroaryl-amino substituted tetracycline compounds |
SI1301467T1 (sl) * | 2000-07-07 | 2007-02-28 | Tufts College | 9-substituirane minociklinske spojine |
CN1450989A (zh) * | 2000-07-07 | 2003-10-22 | 塔夫茨大学信托人 | 7-取代的四环素化合物 |
DE60135387D1 (de) * | 2001-03-13 | 2008-09-25 | Paratek Pharm Innc | 7,9 substituierte tetracyclinverbindungen |
JP2004530661A (ja) * | 2001-03-14 | 2004-10-07 | パラテック ファーマシューティカルズ インコーポレイテッド | 抗真菌剤としての置換テトラサイクリン化合物 |
EP2332549A1 (en) * | 2001-07-13 | 2011-06-15 | Paratek Pharmaceuticals, Inc. | Novel tetracyclines and their use in medicine |
WO2003057169A2 (en) * | 2002-01-08 | 2003-07-17 | Paratek Pharmaceuticals, Inc. | 4-dedimethylamino tetracycline compounds |
US6958161B2 (en) * | 2002-04-12 | 2005-10-25 | F H Faulding & Co Limited | Modified release coated drug preparation |
KR101148415B1 (ko) * | 2002-07-12 | 2012-05-21 | 파라테크 파마슈티컬스, 인크. | 3, 10, 및 12a 치환된 테트라시클린 화합물 |
AU2003274927A1 (en) * | 2002-08-23 | 2004-03-11 | Genome Therapeutics Corporation | Methods and reagents for preventing bacteremias |
AU2003268330A1 (en) * | 2002-08-29 | 2004-03-19 | Activbiotics, Inc. | Methods and reagents for treating infections of clostridium difficile and diseases associated therewith |
US20050148553A1 (en) * | 2003-09-05 | 2005-07-07 | Testa Raymond T. | Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis |
-
2006
- 2006-12-20 JP JP2008547492A patent/JP2009521456A/ja active Pending
- 2006-12-20 BR BRPI0620430-9A patent/BRPI0620430A2/pt not_active Application Discontinuation
- 2006-12-20 EP EP06847831A patent/EP1962860A1/en not_active Withdrawn
- 2006-12-20 AU AU2006331685A patent/AU2006331685A1/en not_active Abandoned
- 2006-12-20 CA CA002631632A patent/CA2631632A1/en not_active Abandoned
- 2006-12-20 KR KR1020087017967A patent/KR20080085184A/ko not_active Application Discontinuation
- 2006-12-20 RU RU2008121238/14A patent/RU2008121238A/ru not_active Application Discontinuation
- 2006-12-20 WO PCT/US2006/048617 patent/WO2007075792A1/en active Application Filing
- 2006-12-20 CN CNA2006800477777A patent/CN101340917A/zh active Pending
- 2006-12-21 US US11/642,522 patent/US20070243244A1/en not_active Abandoned
-
2008
- 2008-05-21 IL IL191598A patent/IL191598A0/en unknown
- 2008-05-27 CR CR10023A patent/CR10023A/es not_active Application Discontinuation
- 2008-05-27 NO NO20082396A patent/NO20082396L/no not_active Application Discontinuation
- 2008-06-19 GT GT200800115A patent/GT200800115A/es unknown
- 2008-07-18 EC EC2008008634A patent/ECSP088634A/es unknown
Also Published As
Publication number | Publication date |
---|---|
CN101340917A (zh) | 2009-01-07 |
CA2631632A1 (en) | 2007-07-05 |
US20070243244A1 (en) | 2007-10-18 |
JP2009521456A (ja) | 2009-06-04 |
WO2007075792A1 (en) | 2007-07-05 |
IL191598A0 (en) | 2009-08-03 |
RU2008121238A (ru) | 2010-01-27 |
BRPI0620430A2 (pt) | 2011-11-08 |
KR20080085184A (ko) | 2008-09-23 |
NO20082396L (no) | 2008-08-26 |
CR10023A (es) | 2008-08-21 |
ECSP088634A (es) | 2008-08-29 |
EP1962860A1 (en) | 2008-09-03 |
AU2006331685A1 (en) | 2007-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT200800115A (es) | Metodos para tratar infecciones del tracto gastrointestinal con tigeciclina | |
CL2007003686A1 (es) | Compuestos derivados de indol con anillo unido en las posiciones 4,5; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para tratar una infeccion viral. | |
CL2007002594A1 (es) | Compuestos derivados de piridin-3-il, agentes inmunomoduladores; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de enfermedades asociadas con un sistema inmunologico activado. . | |
EA200901617A1 (ru) | Борсодержащие молекулы небольшого размера | |
CL2009000393A1 (es) | Composición farmaceutica que comprende a) un agente farmaceutico activable, b) un agente activo plasmonico; util para el tratamiento de trastornos de proliferación celular. | |
BR112015014562A2 (pt) | composições pesticidas e processos com estas relacionados | |
CL2014002969A1 (es) | Formulaciones farmacéuticas tópicas no acuosas que comprende a) agente antimicrobiano 0,01%-80%, b) disolvente organico con propiedad de permeacion, c) codisolvente organico y d) agente peliculigeno; y su uso para infecciones fungicas, viricas, protozoarias o bacterianas | |
CL2008001124A1 (es) | Formulacion farmaceutica que comprende al menos un derivado de acido lipoico y un reactivo formador de par ionico, util en el tratamiento del cancer. | |
MX2009008617A (es) | Uso de antagonistas de interleucina-23 para el tratamiento de infeccion. | |
BRPI0815773A2 (pt) | composto, e, medicamento. | |
MX2009006846A (es) | Derivados de tetraciclina para el tratamiento de infecciones bacterianas, virales y parasitarias. | |
EA201000903A1 (ru) | Антитела к pcrv-антигену pseudomonas aeruginosa | |
ECSP099634A (es) | Derivados de piridazinona útiles como inhibidores de glucano sintasa | |
CL2007003192A1 (es) | Compuestos derivados de arilamidas sustituidas por tiazol u oxazol; composicion farmaceutica; y uso para el tratamiento de una enfermedad del tracto urinario. | |
WO2017083515A3 (en) | Antibody molecule-drug conjugates that specifically binds to lipopolysaccharide and uses thereof | |
GT200600097A (es) | Formas farmaceuticas con propiedades farmacocineticas mejoradas | |
EA201200484A1 (ru) | Фармацевтическая композиция с действующими веществами - метформином и ситаглиптином или вилдаглиптином | |
CL2011003327A1 (es) | Composicion farmaceutica que comprende finafloxacina y un agente antiinflamatorio; uso en el tratamiento de infecciones oftalmicas, oticas o nasales. | |
BRPI0815578A2 (pt) | Peptídeo de cdca1 e agente farmacêutico compreendendo o mesmo. | |
ECSP11011354A (es) | Composiciones óticas útiles para el tratamiento de infecciones del oído interno y externo en maíferos | |
CL2007002671A1 (es) | Compuestos derivados de octahidro-pirrolo[3,4-c]pirrol; composicion farmaceutica que la comprende; y uso del compuesto en el tratamiento del vih, sida o arc. | |
CL2011000165A1 (es) | Compuestos derivados de indolinonas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento y/o la prevencion del cancer, infecciones, enfermedades inflamatorias y autoinmunes. | |
CL2008001728A1 (es) | Compuestos derivados de indolinonas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de cancer, infecciones, enfermedades inflamatorias y autoinmunes. | |
CL2007001542A1 (es) | Compuestos derivados de aminotiazoles, composicion farmaceutica; y uso para el tratamiento de infecciones bacterianas. | |
CL2007003847A1 (es) | Compuestos derivados de pirimidinas 2,4,5 tri-sustituidas; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento del cancer. |